Introduction
Myocarditis, inflammation of the heart muscle, can strike at any age. But children and adults do not always experience this disease the same way. A new review (Ricci et al., 2025) explains how myocarditis differs between pediatric and adult patients in terms od causes, immune behavior, diagnosis, and management. Understanding these distinctions is critical for improving care, especially for younger patients, and for driving research toward age-appropriate therapies. In this post, we’ll break down the review’s key insights in accessible language and highlight their relevance to the myocarditis community.
Why We Need to Look Separately at Pediatric vs Adult Myocarditis
Different Drivers and Risk Patterns
While viral infections (e.g. enteroviruses, coxsackieviruses) remain leading causes in both children and adults, factors such as hormones (e.g. sex hormones) and immune maturation may influence how myocarditis manifests, progresses, and resolves differently across ages. Also, in adults, some causes like immune checkpoint inhibitors or autoimmune conditions are better documented; these are less well studied in children.
Variation in Immune Response
The authors discuss how innate and adaptive immunity (macrophages, T cells, B cells) interact differently in younger vs older patients, which may affect how strongly and how long the inflammation persists.
Challenges in Recognizing Myocarditis in Kids
Children may present with non-specific symptoms (e.g. fatigue, malaise) rather than classic chest pain, making diagnosis harder. Also, validated biomarkers and risk stratification tools are lacking pediatric populations, so clinicians often borrow adult strategies- this may lead to underdiagnosis or misclassification in children.
Treatment Gaps
Many therapeutic decisions (immunosuppression, heart failure therapy, monitoring) are based on adult data. But children may respond differently, have different side-effects profiles, or require different dosing or timing. The authors argue for pediatric- specific trials and protocols rather than extrapolation from adult evidence.
Key Insights & Implications for Patients and Families
| Theme | What the Review Found | Why It Matters to You |
| Sex & Hormones | Adult myocarditis shows male predominance, possibly tied to sex hormones; pediatric data are sparse but suggest these influences begin early. | It may help explain why some children, especially boys, appear more vulnerable. This could inform future screening or monitoring strategies. |
| No “One Size Fits All” Biomarker | There is no reliable, universally accepted biomarker or panel that predicts severity or progression; reliance on echo, MRI, biopsy, and clinical judgement. | Patients and clinicians should understand that diagnosis and prognoses remain uncertain; vigilance is key. |
| Need for More Pediatric Research | The authors highlight that pediatric myocarditis is understudied, especially in randomized trials and mechanistic studies. | Advocacy and funding for pediatric myocarditis research can help drive better diagnostics and treatments tailored to younger patients. |
| Toward Personalized Care by Age/ Sex | The review suggests future strategies may stratify care by age, sex, and immune profile, rather than treating all myocarditis patients the same. | Over time, this may lead to more precise treatments, fewer side effects, and better outcomes. |
Call to Action & Future Directions
This review underscores a critical point: children with myocarditis are not “small adults.” We need more targeted research, pediatric clinical trials, and deeper mechanistic studies of how the immune system behaves in younger hearts. For the Myocarditis Foundation community, this is a rallying cry – for funding, advocacy, collaboration, and awareness that pediatric myocarditis deserves its own spotlight.
If you or someone you know has experienced myocarditis in youth, stay connected, ask about opportunities to participate in research, and support efforts that push for age-tailored care. Together, we can help drive the field from “extrapolation” to “precision for every age.”
